Left sidebar

Lorem Ipsum is simply dummy text of the printing.
Posted by The Analyst | 19 August 2020 | Politics
A different view of the Democrats on Fox News prime time

Tucker Carlson and Sean Hannity are providing television viewers with a distinctly different vision of the Democratic National Convention each night from their perches on Fox News Channel. Hannity calls … Click to Continue »

Continue Reading
Posted by The Analyst | 19 August 2020 | Politics
Editorial Roundup: Alabama

Recent editorials from Alabama newspapers: ___ Aug. 18 The Times Daily on taxing coronavirus relief funds: Unless the state Legislature acts, families, individuals and businesses that received federal coronavirus relief … Click to Continue »

Continue Reading
Posted by The Analyst | 19 August 2020 | Politics
Editorial Roundup: Mississippi

Recent editorials from Mississippi newspapers: ___ Aug. 19 The Commercial Dispatch on a former chief financial officer of a Mississippi city accused of embezzling nearly $290,000: The arrest of former … Click to Continue »

Continue Reading
Posted by The Analyst | 19 August 2020 | Politics
Editorial Roundup: North Carolina

Recent editorials from North Carolina newspapers: ___ Aug. 18 Winston-Salem Journal on unemployment benefits amid the coronavirus pandemic: In tough times, a little bit of help is better than none … Click to Continue »

Continue Reading
Posted by The Analyst | 19 August 2020 | Politics
Facebook bans some, but not all, QAnon groups, accounts

Facebook says it will restrict the right-wing conspiracy movement QAnon and will no longer recommend that users join groups supporting it, although the company isn't banning it outright. Facebook said … Click to Continue »

Continue Reading
Posted by The Analyst | 19 August 2020 | Politics
Closing prices for crude oil, gold and other commodities

Benchmark U.S. crude oil for September delivery rose 4 cents to $42.93 a barrel Wednesday. Brent crude oil for October delivery fell 9 cents to $45.37 a barrel. Wholesale gasoline … Click to Continue »

Continue Reading
Posted by The Analyst | 19 August 2020 | Politics
FDA blocks much-anticipated BioMarin hemophilia gene therapy

Investors fled drug developer BioMarin in droves on Wednesday, driving shares down by a third after U.S. regulators rejected the company's potentially game-changing hemophilia A gene therapy over concerns it … Click to Continue »

Continue Reading